- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource, 1 online resource.
- Sprache
-
Englisch
- Erschienen in
-
Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis ; volume:10 ; number:5 ; day:3 ; month:7 ; year:2023 ; pages:1119-1125 ; date:10.2023
Rheumatology and therapy ; 10, Heft 5 (3.7.2023), 1119-1125, 10.2023
- Urheber
-
Lubrano, Ennio
Scriffignano, Silvia
Perrotta, Fabio Massimo
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s40744-023-00574-w
- URN
-
urn:nbn:de:101:1-2023110809503917030305
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:49 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lubrano, Ennio
- Scriffignano, Silvia
- Perrotta, Fabio Massimo
- SpringerLink (Online service)
Ähnliche Objekte (12)
Clinical Characteristics of Potential “Difficult-to-treat” Patients with Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort
Cefiderocol in Difficult-to-Treat Nf-GNB in ICU Settings
Difficult-to-treat HIV in Sweden: a cross-sectional study
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients
Psoriatic arthritis with hyperuricemia: more peripheral, destructive, and challenging to treat
Novel Concepts in Psoriatic Arthritis Management: Can We Treat to Target?
EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
Accelerometer-derived sleep metrics in mild and difficult-to-treat asthma
Correction: Cefiderocol in Difficult-to-Treat Nf-GNB in ICU Settings
The potential role of fatigue in difficult-to-treat rheumatoid arthritis
Is Baricitinib Effective and Safe for Patients with Difficult-to-Treat Rheumatoid Arthritis? Comparative Data with the Rheumatoid Arthritis Group of Rheumatoid Arthritis Not Difficult to Treat
Antihistamine updosing reduces disease activity in difficult-to-treat cholinergic urticaria patients
Clinical Characteristics of Potential “Difficult-to-treat” Patients with Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort
Cefiderocol in Difficult-to-Treat Nf-GNB in ICU Settings
Difficult-to-treat HIV in Sweden: a cross-sectional study
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients
Psoriatic arthritis with hyperuricemia: more peripheral, destructive, and challenging to treat
Novel Concepts in Psoriatic Arthritis Management: Can We Treat to Target?
EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
Accelerometer-derived sleep metrics in mild and difficult-to-treat asthma
Correction: Cefiderocol in Difficult-to-Treat Nf-GNB in ICU Settings
The potential role of fatigue in difficult-to-treat rheumatoid arthritis
Is Baricitinib Effective and Safe for Patients with Difficult-to-Treat Rheumatoid Arthritis? Comparative Data with the Rheumatoid Arthritis Group of Rheumatoid Arthritis Not Difficult to Treat
Antihistamine updosing reduces disease activity in difficult-to-treat cholinergic urticaria patients
Clinical Characteristics of Potential “Difficult-to-treat” Patients with Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort
Cefiderocol in Difficult-to-Treat Nf-GNB in ICU Settings
Difficult-to-treat HIV in Sweden: a cross-sectional study
CGRP-monoclonal antibodies in difficult-to-treat chronic migraine patients
Psoriatic arthritis with hyperuricemia: more peripheral, destructive, and challenging to treat
Novel Concepts in Psoriatic Arthritis Management: Can We Treat to Target?
EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
Accelerometer-derived sleep metrics in mild and difficult-to-treat asthma
Correction: Cefiderocol in Difficult-to-Treat Nf-GNB in ICU Settings
The potential role of fatigue in difficult-to-treat rheumatoid arthritis
Is Baricitinib Effective and Safe for Patients with Difficult-to-Treat Rheumatoid Arthritis? Comparative Data with the Rheumatoid Arthritis Group of Rheumatoid Arthritis Not Difficult to Treat